Vimarsana
Biggest News Aggregation in the World

Page 2 - Third Leading Cause News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Third Leading Cause. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Third Leading Cause Today - Breaking & Trending Today

Persecution of doctors under Covid - Vimarsana News

Persecution of doctors under Covid

Respect and admiration is owed to those dissenting doctors who have been persecuted for challenging the official Covid narrative.

Health Officials Backtrack, Did They Just Admit This? - Vimarsana News

Health Officials Backtrack, Did They Just Admit This?

Imagine calling out 'misinformation spreaders' for two years, then publishing updated guidance matching exactly what those spreaders been ...

COVID-19 Again the Third-Leading Cause of US Deaths - Vimarsana News

COVID-19 Again the Third-Leading Cause of US Deaths

The 2021 death rate was the highest since 2003, the CDC said.

COVID-19 Reported as Third Leading Cause of Death in 2020 in the U.S. -- Occupational Health & Safety - Vimarsana News

COVID-19 Reported as Third Leading Cause of Death in 2020 in the U.S. -- Occupational Health & Safety

Federal health researchers report the study from the past year. By Shereen Hashem Apr 02, 2021 Following heart disease and cancer, COVID-19 was officially the third leading cause of death in 2020. This displaced unintentional injuries as the usual third place spot, federal health researchers reported. Coronavirus took 345,323 lives of Americans solely last year. According to the National Center for Health Statistics, in about 30,000 additional cases, death certificates cited COVID-19, however, it wasn’t considered the cause of death. In addition to COVID-19, heart disease, diabetes and Alzh...

AMGEN TO ACQUIRE FIVE PRIME THERAPEUTICS FOR $1.9 BILLION IN CASH - Vimarsana News

AMGEN TO ACQUIRE FIVE PRIME THERAPEUTICS FOR $1.9 BILLION IN CASH

Bemarituzumab is a Strong Strategic Fit With Amgen’s Innovative Oncology Portfolio Amgen to Host Investor Call at 10:30 a.m. EST THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 4, 2021 – Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies, today announced an agreement under which Amgen will acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of approximately $1.9 billion. This acquisition adds Five Prime’s innovative ...